{"database": "lobbying", "table": "lobbying_activities", "rows": [[253732, "a72a19d5-6f7f-40aa-829c-7ff222eb44dc", "YY", "D. LYNN JOHNSON", 86653, "KING PHARMACEUTICALS INC", 2003, "year_end", "PHA", "Asked a Senate office to contact the FDA to determine why the agency would not agree to King Pharmaceuticals' promoting the use of AtroPen (approved by the FDA) with physicians and the public by using FDA approved informational materials.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2004-01-06T00:00:00-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["253732"], "units": {}, "query_ms": 1.6089060809463263, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}